Pronostics has signed a deal with Hannover Medical School to provide its proprietary platform for the diagnosis of autoimmune disease.
The deal, which is through Pronostics' German distributor, Medipan, will see Hannover Medical School use the Ultraplex hardware and ANA kits.
Pronostics said Ultraplex eliminates the possibility of subjective errors, removes non-specific positive results and focuses on clinically significant results, with known disease association.
It added that its introduction into the medical school will also reduce test turnaround times and laboratory costs.
The Ultraplex ANA assay consists of 11 tests in one, providing time and cost savings compared to serial testing approaches or current multiplexing methods.
It allows hospitals and laboratories to perform fully automated tests on patient samples and gives both quantitative and qualitative results for antibodies in autoimmune diseases.
